Kiora Pharmaceuticals Analyst Ratings
Kiora Pharmaceuticals Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 263.64% | HC Wainwright & Co. | $7 → $2 | Maintains | Buy |
| 08/09/2023 | 263.64% | Maxim Group | $12 → $2 | Maintains | Buy |
| 05/12/2023 | 1172.73% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 03/24/2023 | 990.91% | HC Wainwright & Co. | $10 → $6 | Reiterates | → Buy |
| 02/09/2023 | 2081.82% | Maxim Group | → $12 | Upgrades | Hold → Buy |
| 02/08/2023 | 1718.18% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 02/08/2023 | 21536.36% | Ladenburg Thalmann | → $119 | Reiterates | → Buy |
| 08/25/2022 | 1081.82% | Ladenburg Thalmann | → $6.5 | Initiates Coverage On | → Buy |
| 08/15/2022 | — | Maxim Group | Downgrades | Buy → Hold | |
| 07/11/2022 | 354.55% | HC Wainwright & Co. | $3 → $2.5 | Maintains | Buy |
| 04/19/2022 | 445.45% | HC Wainwright & Co. | $5 → $3 | Maintains | Buy |
| 01/19/2022 | 354.55% | Maxim Group | → $2.5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/14/2023 | 263.64% | HC Wainwright & Co. | 7 美元 → 2 美元 | 維護 | 購買 |
| 08/09/2023 | 263.64% | Maxim 集團 | 12 美元 → 2 美元 | 維護 | 購買 |
| 05/12/2023 | 1172.73% | HC Wainwright & Co. | 6 美元 → 7 美元 | 維護 | 購買 |
| 2023 年 3 月 24 日 | 990.91% | HC Wainwright & Co. | 10 美元 → 6 美元 | 重申 | → 購買 |
| 02/09/2023 | 2081.82% | Maxim 集團 | → 12 美元 | 升級 | 持有 → 買入 |
| 02/08/2023 | 1718.18% | HC Wainwright & Co. | → 10 美元 | 重申 | → 購買 |
| 02/08/2023 | 21536.36% | 拉登堡塔爾曼 | → 119 美元 | 重申 | → 購買 |
| 08/25/2022 | 1081.82% | 拉登堡塔爾曼 | → 6.5 美元 | 啓動覆蓋開啓 | → 購買 |
| 08/15/2022 | — | Maxim 集團 | 降級 | 買入 → 持有 | |
| 2022 年 11 月 7 日 | 354.55% | HC Wainwright & Co. | $3 → 2.5 美元 | 維護 | 購買 |
| 04/19/2022 | 445.45% | HC Wainwright & Co. | 5 美元 → 3 美元 | 維護 | 購買 |
| 2022 年 1 月 19 日 | 354.55% | Maxim 集團 | → 2.5 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for Kiora Pharmaceuticals (KPRX)?
Kiora Pharmicals（KPRX）的目標價格是多少？
The latest price target for Kiora Pharmaceuticals (NASDAQ: KPRX) was reported by HC Wainwright & Co. on August 14, 2023. The analyst firm set a price target for $2.00 expecting KPRX to rise to within 12 months (a possible 263.64% upside). 9 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月14日公佈了Kiora Pharmicals（納斯達克股票代碼：KPRX）的最新目標股價。這家分析公司將目標股價定爲2.00美元，預計KPRX將在12個月內升至12個月內（可能上漲263.64％）。去年有9家分析公司公佈了評級。
What is the most recent analyst rating for Kiora Pharmaceuticals (KPRX)?
Kiora Pharmicals（KPRX）的最新分析師評級是多少？
The latest analyst rating for Kiora Pharmaceuticals (NASDAQ: KPRX) was provided by HC Wainwright & Co., and Kiora Pharmaceuticals maintained their buy rating.
Kiora Pharmicals（納斯達克股票代碼：KPRX）的最新分析師評級由HC Wainwright & Co. 提供，Kiora Pharmicals維持買入評級。
When is the next analyst rating going to be posted or updated for Kiora Pharmaceuticals (KPRX)?
Kiora Pharmicals（KPRX）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kiora Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kiora Pharmaceuticals was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Kiora Pharmicals的高管和客戶交談以及聽取業績電話會議）後得出了股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Kiora Pharmicals的最新評級是在2023年8月14日提交的，因此您應該預計下一個評級將在2024年8月14日左右公佈。
Is the Analyst Rating Kiora Pharmaceuticals (KPRX) correct?
分析師對Kiora Pharmicals（KPRX）的評級正確嗎？
While ratings are subjective and will change, the latest Kiora Pharmaceuticals (KPRX) rating was a maintained with a price target of $7.00 to $2.00. The current price Kiora Pharmaceuticals (KPRX) is trading at is $0.55, which is out of the analyst's predicted range.
儘管評級是主觀的，將會發生變化，但最新的Kiora Pharmicals（KPRX）評級維持不變，目標股價爲7.00美元至2.00美元。Kiora Pharmicals（KPRX）目前的交易價格爲0.55美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。